Xu Stella 4/A
4/A · Tempest Therapeutics, Inc. · Filed Sep 20, 2021
Insider Transaction Report
Form 4/AAmended
Xu Stella
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-01+6,635→ 6,635 totalExercise: $11.07Exp: 2031-06-30→ Common Stock (6,635 underlying)
Footnotes (2)
- [F1]Vests over three (3) years, with one-third (1/3) of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.
- [F2]The reporting person holds these securities for the benefit of Quan Venture Fund I, L.P. ("Quan Capital"). The general partner of Quan Capital is Quan Venture Partners I, L.L.C. The reporting person is amanager of Quan Venture Partners I, L.L.C. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest. This report on Form 4 shall not be deemed anadmission the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.